Oxford Biodynamics Plc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oxford Biodynamics Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10695
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company’s products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, Oxfordshire, the UK.

Oxford Biodynamics Plc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Devices Deals, 2012 to YTD 2018 9
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
GL Capital Invests USD12.5 Million in Oxford BioDynamics 11
Partnerships 13
Oxford BioDynamics Enters into Agreement with US Biopharma Company for Biomarkers 13
Oxford BioDynamics Enters into Agreement with US Biopharma Company 14
Oxford Biodynamics Enters into Development Agreement with Two Pharmaceutical Companies 15
Equity Offering 16
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 16
Oxford Biodynamics Plc – Key Competitors 17
Oxford Biodynamics Plc – Key Employees 18
Oxford Biodynamics Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 22, 2018: Oxford Biodynamics: Interim Results For The Six-Month Period Ended 31 March 2018 20
Jan 30, 2018: Oxford BioDynamics Reports Revenue of £1.2m For The Year Ended 30 September 2017 21
Jun 13, 2017: Oxford Biodynamics Interim Results For The Six-Month Period Ended 31 March 2017 22
Jan 31, 2017: Oxford BioDynamics Announces Final Results for the Year Ended 30 September 2016 27
Corporate Communications 29
Sep 15, 2017: Oxford BioDynamics appoints Paul Stockdale as Chief Financial Officer and Executive Director on the Board 29
Jun 30, 2017: Oxford BioDynamics: Appointment of Paul Stockdale as Chief Financial Officer 30
Mar 09, 2017: Oxford BioDynamics announces appointment of Martin Reeves as Senior Vice President of Commercial Development 31
Feb 13, 2017: Oxford BioDynamics appoints Dr Claudio Carini as an Advisor 32
Government and Public Interest 33
Sep 18, 2018: Consortium including Oxford BioDynamics receives €4 million Horizon 2020 award 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Key Facts 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Devices Deals, 2012 to YTD 2018 9
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GL Capital Invests USD12.5 Million in Oxford BioDynamics 11
Oxford BioDynamics Enters into Agreement with US Biopharma Company for Biomarkers 13
Oxford BioDynamics Enters into Agreement with US Biopharma Company 14
Oxford Biodynamics Enters into Development Agreement with Two Pharmaceutical Companies 15
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 16
Oxford Biodynamics Plc, Key Competitors 17
Oxford Biodynamics Plc, Key Employees 18
Oxford Biodynamics Plc, Other Locations 19

List of Figures
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oxford Biodynamics Plc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Broadwind Energy Inc (BWEN):企業の財務・戦略的SWOT分析
    Broadwind Energy Inc (BWEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Avalon Oil & Gas Inc (AOGN):企業の財務・戦略的SWOT分析
    Summary Avalon Oil & Gas Inc (Avalon), is an oil and gas company that develops and operates crude oil and natural gas properties. The company acquires, produces and develops oil and natural gas reserves. It offers reservoir maintenance and technologies to produce portfolio of oil and gas leases in t …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • Dyadic International Inc (DYAI)-製薬・医療分野:企業M&A・提携分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that discovers, develops, manufactures and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila (C1) expression system, to conduct research and produce industria …
  • Roche Diagnostics Corp:企業のM&A・事業提携・投資動向
    Roche Diagnostics Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roche Diagnostics Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Rush Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bottomline Technologies (de), Inc. (EPAY):企業の財務・戦略的SWOT分析
    Bottomline Technologies (de), Inc. (EPAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Magnetek Inc:企業の戦略的SWOT分析
    Magnetek Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Data Respons ASA (DAT):企業の財務・戦略的SWOT分析
    Summary Data Respons ASA (Data Respons) is an information technology company that offers software products and embedded solutions. The company's products include storage and memory, handheld tablets, embedded boards, panel PCs and displays, systems and platforms, and industrial communication product …
  • Takuma Co Ltd (6013):企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mahindra & Mahindra Limited:企業の戦略・SWOT・財務情報
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Clevexel Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …
  • Societe Generale Private Banking:企業の戦略・SWOT・財務情報
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Helmerich & Payne Inc (HP):企業の財務・戦略的SWOT分析
    Helmerich & Payne Inc (HP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fukoku Mutual Life Insurance Company
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Lassonde Industries Inc.:戦略・SWOT・企業財務分析
    Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BWX Technologies Inc (BWXT):電力:M&Aディール及び事業提携情報
    Summary BWX Technologies Inc (BWXT) is a specialty manufacturer of nuclear components. It designs, engineers, and manufactures precision naval nuclear components, reactors, and nuclear fuel for the US Government. The company also provides special nuclear materials processing and environmental site r …
  • Innergex Renewable Energy Inc (INE)-エネルギー分野:企業M&A・提携分析
    Summary Innergex Renewable Energy Inc. (Innergex) is an electricity services company that develops, owns, and operates renewable power-generating facilities. It sells electricity that is generated from hydro, wind, and solar sources. The company sells electricity through long-term power purchase agr …
  • Intertech Bilgi Islem ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Meiji Co Ltd:企業の戦略・SWOT・財務分析
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆